| Drug Name | Tremelimumab |
|---|---|
| Other Drug Names | TICILIMUMAB; CP-675,206 |
| Chemical Name | immunoglobulin G2, anti-(human CTLA-4 (antigen)) (human monoclonal CP-675206 clone 11.2.1 heavy chain), disulfide with human monoclonal CP-675206 clone 11.2.1 light chain, dimer |
| Formula | C65000H9974N1726O2026S52 |
| Mol. Wt. | approximately 150 kDa |
| CAS No. | 745013-59-6 |
| UNII | QEN1X95CIX |
| Target-based Actions | Cytotoxic T-lymphocyte protein-4 inhibitor |
| ATC Codes | L01XC |
| Originator Company | Boehringer Ingelheim for Pfizer |
| Structure |
 |
Extended Information